Abstract
Increasing awareness of the potential risks of ionizing radiation in imaging has led oncologists and radiologists to review many aspects of how and when pediatric oncology patients are imaged, with a greater emphasis on study justification and dose optimization. In this chapter we will review the background to current concerns regarding potential future increased malignancy risk, discuss dose estimation, provide an overview of dose optimization strategies and typical radiation doses for commonly performed studies, and, finally, discuss some of the issues and challenges around communication with patients and their families.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
NCI. SEER cancer statistics review, 1975-2014. Bethesda, MD: National Cancer Institute; 2017. https://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017.
McHugh K, Roebuck DJ. Pediatric oncology surveillance imaging: two recommendations. Abandon CT scanning, and randomize to imaging or solely clinical follow-up. Pediatr Blood Cancer. 2014;61(1):3–6.
Bhatia S, Yasui Y, Robison LL, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: report from the Late Effects Study Group. J Clin Oncol. 2003;21(23):4386–94.
Garwicz S, Anderson H, Olsen JH, et al. Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries. Int J Cancer. 2000;88(4):672–8.
Ozasa K, Shimizu Y, Suyama A, et al. Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases. Radiat Res. 2011;177(3):229–43.
National Research Council. Committee to assess health risks from exposure to low levels of ionizing radiation. Health risks from exposure to low levels of ionizing radiation: Beir VII Phase II. Washington, DC: National Academic Press; 2006.
Siegel JA, Pennington CW, Sacks B. Subjecting radiologic imaging to the linear no-threshold hypothesis: a non sequitur of non-trivial proportion. J Nucl Med. 2017;58(1):1–6.
UNSCotEoAR. Effects of radiation exposure of children. Vol II Annex B. New York, NY: UNSCEAR, United Nations; 2013.
Martin CJ. Effective dose: how should it be applied to medical exposures? Br J Radiol. 2007;80(956):639–47.
Harrison JD, Balonov M, Martin CJ, et al. Use of effective dose. Ann ICRP. 2016;45(1 Suppl):215–24.
Fisher DR, Fahey FH. Appropriate use of effective dose in radiation protection and risk assessment. Health Phys. 2017;113(2):102–9.
Mettler FA Jr, Huda W, Yoshizumi TT, Mahesh M. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology. 2008;248(1):254–63.
Ahmed BA, Connolly BL, Shroff P, et al. Cumulative effective doses from radiologic procedures for pediatric oncology patients. Pediatrics. 2010;126(4):e851–8.
Owens C, Li BK, Thomas KE, Irwin MS. Surveillance imaging and radiation exposure in the detection of relapsed neuroblastoma. Pediatr Blood Cancer. 2016;63(10):1786–93.
Glatz AC, Purrington KS, Klinger A, et al. Cumulative exposure to medical radiation for children requiring surgery for congenital heart disease. J Pediatr. 2014;164(4):789–794.e710.
WHO. Communicating radiation risks in paediatric imaging: information to support health care discussions about benefit and risk. Geneva: World Health Organization; 2016.
Fahey FH, Treves ST, Adelstein SJ. Minimizing and communicating radiation risk in pediatric nuclear medicine. J Nucl Med. 2011;52(8):1240–51.
Smith-Bindman R, Lipson J, Marcus R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med. 2009;169(22):2078–86.
Thomas KE. CT update: use, dose variability and diagnostic reference levels. Diagn Imaging Eur. 2012;(July):27–30.
Lee C, Pearce MS, Salotti JA, et al. Reduction in radiation doses from paediatric CT scans in Great Britain. Br J Radiol. 2016;89(1060):20150305.
Chong AL, Grant RM, Ahmed BA, Thomas KE, Connolly BL, Greenberg M. Imaging in pediatric patients: time to think again about surveillance. Pediatr Blood Cancer. 2010;55(3):407–13.
Pierobon J, Webber CE, Nayiager T, Barr RD, Moran GR, Gulenchyn KY. Radiation doses originating from diagnostic procedures during the treatment and follow-up of children and adolescents with malignant lymphoma. J Radiol Prot. 2011;31(1):83–93.
Chawla SC, Federman N, Zhang D, et al. Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective review. Pediatr Radiol. 2010;40(5):681–6.
Nievelstein RA, Quarles van Ufford HM, Kwee TC, et al. Radiation exposure and mortality risk from CT and PET imaging of patients with malignant lymphoma. Eur Radiol. 2012;22(9):1946–54.
Boutis K, Thomas KE. Radiation dose awareness and disclosure practice in paediatric emergency medicine: how far have we come? Br J Radiol. 2016;89(1061):20160022.
Goske MJ, Applegate KE, Boylan J, et al. Image Gently(SM): a national education and communication campaign in radiology using the science of social marketing. J Am Coll Radiol. 2008;5(12):1200–5.
Mayo-Smith WW, Morin RL. Image wisely: the beginning, current status, and future opportunities. J Am Coll Radiol. 2017;14(3):442–3.
SNMMI position statement on dose optimization for nuclear medicine and molecular imaging procedures. 2012. Accessed 22 Dec 2017. http://snmmi.files.cms-plus.com/docs/SNM_Position_Statement_on_Dose_Optimization_FINAL_June_2012.pdf.
Weiser DA, Kaste SC, Siegel MJ, Adamson PC. Imaging in childhood cancer: a Society for Pediatric Radiology and Children’s Oncology Group Joint Task Force report. Pediatr Blood Cancer. 2013;60(8):1253–60.
Seibel NL, Janeway K, Allen CE, et al. Pediatric oncology enters an era of precision medicine. Curr Probl Cancer. 2017;41(3):194–200.
Towbin AJ, Trout AT, Roebuck DJ. Advances in oncologic imaging. Eur J Pediatr Surg. 2014;24(6):474–81.
Rappaport BA, Suresh S, Hertz S, Evers AS, Orser BA. Anesthetic neurotoxicity--clinical implications of animal models. N Engl J Med. 2015;372(9):796–7.
Weller A, Barber JL, Olsen OE. Gadolinium and nephrogenic systemic fibrosis: an update. Pediatr Nephrol. 2014;29(10):1927–37.
Kanal E, Tweedle MF. Residual or retained gadolinium: practical implications for radiologists and our patients. Radiology. 2015;275(3):630–4.
Ramalho J, Semelka RC, Ramalho M, Nunes RH, AlObaidy M, Castillo M. Gadolinium-based contrast agent accumulation and toxicity: an update. AJNR Am J Neuroradiol. 2016;37(7):1192–8.
Racadio JM. Controlling radiation exposure during interventional procedures in childhood cancer patients. Pediatr Radiol. 2009;39(Suppl 1):S71–3.
Goske MJ, Frush DP, Brink JA, Kaste SC, Butler PF, Pandharipande PV. Curbing potential radiation-induced cancer risks in oncologic imaging: perspectives from the ‘image gently’ and ‘image wisely’ campaigns. Oncology (Williston Park). 2014;28(3):232–8. 243.
Nievelstein RA, van Dam IM, van der Molen AJ. Multidetector CT in children: current concepts and dose reduction strategies. Pediatr Radiol. 2010;40(8):1324–44.
Strauss KJ, Goske MJ, Kaste SC, et al. Image gently: ten steps you can take to optimize image quality and lower CT dose for pediatric patients. AJR Am J Roentgenol. 2010;194(4):868–73.
Nelson TR. Practical strategies to reduce pediatric CT radiation dose. J Am Coll Radiol. 2014;11(3):292–9.
Hernanz-Schulman M, Goske MJ, Bercha IH, Strauss KJ. Pause and pulse: ten steps that help manage radiation dose during pediatric fluoroscopy. AJR Am J Roentgenol. 2011;197(2):475–81.
Willis CE. Strategies for dose reduction in ordinary radiographic examinations using CR and DR. Pediatr Radiol. 2004;34(Suppl 3):S196–200. discussion S234–141.
Connolly B, Racadio J, Towbin R. Practice of ALARA in the pediatric interventional suite. Pediatr Radiol. 2006;36(Suppl 2):163–7.
Grant FD, Gelfand MJ, Drubach LA, Treves ST, Fahey FH. Radiation doses for pediatric nuclear medicine studies: comparing the North American consensus guidelines and the pediatric dosage card of the European Association of Nuclear Medicine. Pediatr Radiol. 2015;45(5):706–13.
Lassmann M, Treves ST, Group ESPDHW. Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5. 2008) and the 2010 North American consensus guidelines. Eur J Nucl Med Mol Imaging. 2014;41(5):1036–41.
Treves ST, Gelfand MJ, Fahey FH, Parisi MT. 2016 update of the North American Consensus Guidelines for pediatric administered radiopharmaceutical activities. J Nucl Med. 2016;57(12):15N–8N.
Fahey FH, Bom HH, Chiti A, et al. Standardization of administered activities in pediatric nuclear medicine: a report of the first nuclear medicine global initiative project, Part 2-Current standards and the path toward global standardization. J Nucl Med. 2016;57(7):1148–57.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Thomas, K.E., Fahey, F.H. (2019). Radiation Dose Considerations in Pediatric Oncologic Imaging. In: Voss, S., McHugh, K. (eds) Imaging in Pediatric Oncology. Pediatric Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-03777-2_18
Download citation
DOI: https://doi.org/10.1007/978-3-030-03777-2_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-03776-5
Online ISBN: 978-3-030-03777-2
eBook Packages: MedicineMedicine (R0)